These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 1804283)
21. [Arterial blood pressure behavior during progressive muscular exercise in subjects with stable arterial hypertension]. Seguro C; Sau F; Zedda N; Scano G; Cherchi A Cardiologia; 1991 Nov; 36(11):867-77. PubMed ID: 1817759 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study. Rosei EA; Rizzoni D; J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793 [TBL] [Abstract][Full Text] [Related]
23. The effects of aprotinin, a glandular kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives. Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Manunta F; Rubatti S; Rappelli A Agents Actions Suppl; 1987; 22():373-80. PubMed ID: 2449054 [TBL] [Abstract][Full Text] [Related]
24. Nicardipine versus nifedipine: multicentre controlled trial in essential hypertension. Rumboldt Z; Stojanova D; Drinovec J; Marinković M; Nesović M; Srbinovski M; Bagatin J; Nikodijević B; Stalc A Int J Clin Pharmacol Res; 1988; 8(6):393-400. PubMed ID: 3075601 [TBL] [Abstract][Full Text] [Related]
25. Gender differences of human tissue kallikrein and an erythrocyte kallikrein-like enzyme in essential hypertension. Hughes GS; Margolius HS; Peters R; Oexmann MJ; Chao J; Lindenmayer G J Lab Clin Med; 1988 Nov; 112(5):612-8. PubMed ID: 3183493 [TBL] [Abstract][Full Text] [Related]
26. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems. Ohman KP; Karlberg BE; Nilsson OR; Wettre S Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190 [TBL] [Abstract][Full Text] [Related]
27. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [TBL] [Abstract][Full Text] [Related]
28. Estimation of salt intake by urinary sodium excretion in a Portuguese adult population and its relationship to arterial stiffness. Polónia J; Maldonado J; Ramos R; Bertoquini S; Duro M; Almeida C; Ferreira J; Barbosa L; Silva JA; Martins L Rev Port Cardiol; 2006 Sep; 25(9):801-17. PubMed ID: 17100171 [TBL] [Abstract][Full Text] [Related]
29. Relation of family history of hypertension to platelet aggregation, ratio of total cholesterol to HDL cholesterol and urinary kallikrein excretion. Lin JH; Shiigai T; Takeuchi J Bull Tokyo Med Dent Univ; 1984 Mar; 31(1):13-9. PubMed ID: 6430581 [TBL] [Abstract][Full Text] [Related]
30. Impaired renal kallikrein activity and elevated blood pressure normalized by orally applied kallikrein in essential hypertension. Stumpe KO; Overlack A; Ressel C; Krück F Agents Actions; 1980 Sep; 10(4):349-52. PubMed ID: 6905641 [TBL] [Abstract][Full Text] [Related]
31. Urinary kallikrein excretion in insulin-dependent diabetes mellitus and its relationship to glycemic control. Mayfield RK; Margolius HS; Levine JH; Wohltmann HJ; Loadholt CB; Colwell JA J Clin Endocrinol Metab; 1984 Aug; 59(2):278-86. PubMed ID: 6564131 [TBL] [Abstract][Full Text] [Related]
32. Differing effects of two angiotensin converting enzyme inhibitors, captopril and CI-906, on diuresis and the urinary excretion of kallikrein and prostaglandins in spontaneously hypertensive rats. Säynävälammi P; Pörsti I; Nurmi AK; Seppälä E; Laitinen LA; Manninen V; Ylitalo P; Vapaatalo H Scand J Urol Nephrol Suppl; 1984; 79():23-7. PubMed ID: 6089314 [TBL] [Abstract][Full Text] [Related]
33. Low urinary kallikrein excretion and elevated blood pressure normalized by orally kallikrein in essential hypertension. Overlack A; Stumpe KO; Ressel C; Krück F Clin Sci (Lond); 1979 Dec; 57 Suppl 5():263s-265s. PubMed ID: 261517 [TBL] [Abstract][Full Text] [Related]
34. Urinary kallikrein excretion in essential and mineralocorticoid hypertension. Holland OB; Chud JM; Braunstein H J Clin Invest; 1980 Feb; 65(2):347-56. PubMed ID: 7356684 [TBL] [Abstract][Full Text] [Related]
35. Effects of dietary potassium and race on urinary excretion of kallikrein and aldosterone in man. Horwitz D; Margolius HS; Keiser HR J Clin Endocrinol Metab; 1978 Aug; 47(2):296-9. PubMed ID: 263797 [TBL] [Abstract][Full Text] [Related]
37. Antihypertensive effect of orally administered glandular kallikrein in essential hypertension. Results of double blind study. Overlack A; Stumpe KO; Kolloch R; Ressel C; Krueck F Hypertension; 1981; 3(3 Pt 2):I18-21. PubMed ID: 7021412 [TBL] [Abstract][Full Text] [Related]
38. The effect of aging on urinary kallikrein excretion in normotensive subjects and in patients with essential hypertension. Naka T; Ogihara T; Hata T; Maruyama A; Mikami H; Nakamaru M; Gotoh S; Masuo K; Ohde H; Iwanaga K; Kumahara Y J Clin Endocrinol Metab; 1981 May; 52(5):1023-6. PubMed ID: 6908897 [TBL] [Abstract][Full Text] [Related]
39. Is the renal kallikrein system relevant to sodium sensitivity in patients with essential hypertension. Koolen MI; Daha MR; van Brummelen P Eur J Clin Invest; 1985 Jun; 15(3):151-6. PubMed ID: 3926510 [TBL] [Abstract][Full Text] [Related]